Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 538.00
Bid: 540.00
Ask: 543.00
Change: 2.00 (0.37%)
Spread: 3.00 (0.556%)
Open: 533.00
High: 549.00
Low: 532.00
Prev. Close: 536.00
POLR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AUM Update

14 Apr 2016 07:00

RNS Number : 1355V
Polar Capital Holdings PLC
14 April 2016
 

14 April 2016

Polar Capital Holdings plc

AUM Update

 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist asset management group, today provides its regular quarterly update of its unaudited statement of its Assets under Management ("AUM").

 

Group AUM (unaudited)

 

Polar Capital reports that as at 31 March 2016 its AUM were $10.4bn (£7.3bn) compared to $12.3bn (£8.3bn) at the end of March 2015.

 

AUM movement in

Twelve months to

31 March 2016

USD

GBP

Long only

Funds

Alternative funds

Total

Long only

funds

Alternative funds

Total

AUM at

31 March 2015

$11,185m

$1,071m

$12,256m

£7,548m

£723m

£8,271m

Net subscriptions

/ (redemptions)

$(957)m

$21m

$(936)m

£(634)m

£14m

£(620)m

Market movement

and performance

$(850)m

$(37)m

$(887)m

£(383)m

£(3)m

£(386)m

Total AUM at

31 March 2016

$9,378m

$1,055m

$10,433m

£6,531m

£734m

£7,265m

 

Comment

 

As at the end of March our AUM were £7.3bn, down almost 10% from the level reported at the end of December 2015 and down 12% from the level at the same time last year. Our financial year finished on a disappointing note with a pickup in outflows from our Japan fund following another period of difficult performance.

Prior to the introduction of Abenomics in October 2012 our Japan UCITS had outperformed its benchmark by 57% since its launch in 2001. However, since Abenomics the process that the team deploys has not been able to deliver comparable returns and indeed has underperformed the market by a considerable margin over this period.

This has been disappointing for clients and for the team. The team remain committed to their process and believe at some point the approach will once again deliver significant outperformance for those clients who have an investment horizon beyond the current extreme volatility in Japan.

Although over the last twelve months the AUM across our other funds decreased the reduction has been a product of market moves as net inflows of $240m were received into the Group's non Japan funds over the period.

The breadth of product we are seeing both inflows and interest in from clients gives us confidence that once our Japanese business stabilises, we can once again start growing our AUM and profits. Near term though the outlook for global stock markets remains highly uncertain and this will continue to have an impact on our business over the shorter term.

Polar Capital's focus on investment expertise and our structure, as well as our own recruitment efforts continue to mean we are able to attract additional teams either with assets or whose track-record is such that assets will likely follow quickly. As has recently been reported in the media, we are looking forward to welcoming the highly rated UK Value team of George Godber and Georgina Hamilton to our Group in due course. 

As a consequence of the pipeline of further recruitment activity we now have in place we are revising, for the first time in fifteen years, our targeted number of teams from 10 to 12 to a new range of 12 to 15. We have spent a number of years building up our operational support structure within Polar Capital and this now means we have the necessary resource to offer additional teams the highest level of support, whilst maintaining the culture of our Group.

Our long term performance record remains strong despite the near term challenges posed by recent global market volatility with 14 funds out of our 18 UCITS funds ahead of their benchmark since launch, net of all costs.

Even though our AUM at the end of our financial year are less than had been anticipated, our financial position is such that the Group wishes to confirm to shareholders that it would expect to maintain the dividend at last year's level.

 

For further information please contact:

 

Polar Capital

Tim Woolley (CEO)John Mansell (COO)

+44 (0)20 7227 2700

Canaccord Genuity - Nomad and Joint Broker

Simon Bridges (QE)

Kit Stephenson

+44 (0)20 7523 8000

 

Peel Hunt - Joint Broker

Guy Wiehahn

+44 (0)20 7418 8893

Camarco

Ed Gascoigne-Pees

 

+44 (0)20 3757 4984

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAXLDFENKEFF
Date   Source Headline
26th Nov 20187:00 amRNSUnaudited Interim Results
22nd Nov 20185:00 pmRNSDirectorate Change
5th Nov 20187:01 amRNSNotice of Results
5th Nov 20187:00 amRNSChange of Nominated Adviser and Broker
1st Nov 20187:00 amRNSTotal Voting Rights
25th Oct 20185:26 pmRNSIssue of Equity
24th Oct 20184:52 pmRNSDirector/PDMR Shareholding
17th Oct 20185:49 pmRNSIssue of Equity
15th Oct 201812:38 pmRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
12th Oct 20182:52 pmRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
11th Oct 20184:42 pmRNSIssue of Equity
11th Oct 20187:01 amRNSCrystallisation of business unit & issue of shares
11th Oct 20187:00 amRNSAUM Update
3rd Oct 201810:24 amRNSForm 8.3 - Jardine Lloyd Thompson Group Plc
19th Sep 201811:52 amRNSForm 8.3 - Jardine Lloyd Thompson Group
18th Sep 201812:02 pmRNSForm 8.3 - Realm Therapeutics PLC
17th Aug 20189:27 amRNSDirectorate Change
6th Aug 20187:00 amRNSBlock listing Interim Review
1st Aug 20187:00 amRNSTotal Voting Rights
31st Jul 20185:57 pmRNSIssue of Equity
31st Jul 201811:29 amRNSDirector/PDMR Shareholding
25th Jul 20183:38 pmRNSDirectorate Change
25th Jul 20183:26 pmRNSResult of AGM
19th Jul 201811:13 amRNSForm 8.3 - Consort Medical Plc
18th Jul 20184:21 pmRNSDirector/PDMR Shareholding
18th Jul 201811:50 amRNSForm 8.3 - Consort Medical Plc
17th Jul 201810:58 amRNSForm 8.3 - Consort Medical Plc
16th Jul 20183:44 pmRNSDirector/PDMR Shareholding
12th Jul 201811:50 amRNSForm 8.3 - Consort Medical Plc
12th Jul 20187:00 amRNSAuM Update
11th Jul 201811:06 amRNSForm 8.3 - Consort Medical Plc
3rd Jul 20186:27 pmRNSHolding(s) in Company
3rd Jul 20186:20 pmRNSIssue of Equity
3rd Jul 201812:07 pmRNSForm 8.3 - Consort Medical Plc
2nd Jul 201810:23 amRNSTotal Voting Rights
29th Jun 20187:00 amRNSBlock Listing Application
28th Jun 20185:55 pmRNSAnnual Financial Report
25th Jun 20187:00 amRNSGroup Audited Results for year ended 31 March 2018
11th Jun 201811:27 amRNSNet Asset Value(s)
1st Jun 20187:41 amRNSTotal Voting Rights
24th May 201810:59 amRNSDirector/PDMR Shareholding
24th May 20189:35 amRNSIssue of Equity
23rd May 201811:00 amRNSNotice of Results
23rd May 20189:37 amRNSIssue of Equity
18th May 20181:02 pmRNSIssue of Equity
16th May 20185:49 pmRNSIssue of Equity
11th May 20187:00 amRNSIssue of Equity
10th May 20189:56 amRNSDirector/PDMR Shareholding
1st May 20183:52 pmRNSIssue of Equity
12th Apr 20187:00 amRNSAuM Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.